Toronto is getting an almost $300 million complex dedicated to AI

Thanks to a nearly $300 million investment from a major biopharmaceutical company, Toronto is set to expand its existing AI centre.

The provincial government announced on Monday afternoon that the $294 million gifted from Sanofi, a French pharmaceutical company with offices in North York, will allow Toronto to grow its existing Artificial Intelligence Centre of Excellence which first opened in 2022.

This expansion will also create 50 new "good-paying jobs" in an effort to "make Ontario a global hub for the development of cutting-edge technologies," as Premier Doug Ford states in a news release.

Ontario has become quite the hub for AI talent, producing nearly 100,000 highly skilled STEM graduates every single year. Sanofi says it plans to leverage the deep talent pool to increase Ontario’s expertise in AI, machine learning, as well as pharmaceutical data science.

This isn't the kind of AI hub designed to build the next ChatGPT-like chatbot. Instead, the centre is focused on using AI to advance medical research, improving patient outcomes, and supporting vaccine production that protects millions of Canadians. 

"This investment will create long-term economic opportunity while delivering tangible health benefits for families across the province and the country, including support for life sciences work that enables Sanofi to protect millions of Canadians from infectious disease," says Deputy Premier and Minister of Health Sylvia Jones.

This isn't the first time the French pharma giant has contributed so significantly to Ontario's technology sector. In 2024, Sanofi helped open Canada's largest biomanufacturing facility in North York.

Toronto Mayor Olivia Chow expressed excitement about the multi-million-dollar expansion, saying it can contribute to "better health outcomes for people here and around the world." 

Sanofi currently employs over 2,000 workers across Canada, and every year, its Toronto site not only produces vaccines that protect seven million Canadians against infectious diseases, but also exports these vaccines to over 60 countries around the world.